Nykode Therapeutics AS (OSL:NYKD)
Norway
· Delayed Price · Currency is NOK 2.438
+0.118 (5.09%)
At close: Dec 5, 2025
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 796.12 million as of December 5, 2025. Its market cap has decreased by -2.87% in one year.
Market Cap
796.12M
Enterprise Value
186.54M
Revenue
73.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.44
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 796.12M, a decrease of -85.59%. That is a compound annual growth rate of -28.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 757.59M | -23.83% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | 21.36B | 286.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.70B |
| Nordhealth AS | 2.69B |
| Photocure ASA | 1.68B |
| Thor Medical ASA | 1.54B |
| ArcticZymes Technologies ASA | 1.08B |
| Omda AS | 953.61M |
| Vistin Pharma ASA | 873.59M |
| Gentian Diagnostics ASA | 842.06M |